drugset

drugset / Trial / NCT00225485

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

NCT00225485 ↗

Phase 3 Completed 100 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

Non-randomizedSingle-groupOpen-labelPrevention

Summary

Phase III study evaluating Effexor XR in elderly patients with major depression.

Timeline

Start: 2003-12
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Venlafaxine	Small molecule	—	—

Indications